Yu Li

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Peritoneal Dialysis

Recombinant Human

Chronic Kidney Disease

Top Venues

Thoracic cancer

The clinical respiratory journal

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Mingtao Liu, Hui Li, Ranran Guo, Xia Yu, Yu Li
The inhibitory effect of apatinib on different small cell lung cancer cells and in lung cancer-bearing mice and patients. The clinical respiratory journal 18 (2) (2024)
Mingtao Liu, Hui Li, Ranran Guo, Xia Yu, Yu Li
The inhibitory effect of apatinib on different small cell lung cancer cells and in lung cancer-bearing mice and patients. The clinical respiratory journal 18 (2) (2024)
Pengfei Pan, Fengjuan Wu, Zhiyun Xu, Xiang Ji, Qian Qi, Xiaomin Huang, Ruyue Zhao, Mingtao Liu, Peng Jiang, Yu Li, Lisheng Xu
Intrapleural treatment in patients with non-small cell lung cancer with malignant pleural effusions in the real world. Thoracic cancer (2021)
Peng Jiang, Yan Zhang, Jiadong Cui, Xiuxiu Wang, Yu Li
Inhibitory effects of icotinib combined with antiangiogenic drugs in human non-small cell lung cancer xenograft models are better than single target drugs. Thoracic cancer (2021)
Jiaojiao Pang, Tonghui Xu, Gianmarco Aondio, Yu Li, Alberto Fumagalli, Ming Lu, Giuseppe Valmadre, Jie Wei, Yuan Bian, Margherita Canesi, Giovanni Damiani, Yuan Zhang, Dexin Yu, Jun Chen, Xiang Ji, Wenhai Sui, Bailu Wang, Shuo Wu, Attila Kovacs, Miriam Revera, Hao Wang, Xu Jing, Ying Zhang, Yu-Guo Chen, Yihai Cao
Efficacy and tolerability of bevacizumab in patients with severe Covid-19. Nature communications 12 (1) (2021)